We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Mayer, SA, Brun, NC, Begtrup, K, Broderick, J, Davis, S, Diringer, MN, et al.Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med.2005 Feb 24;352(8): 777–85.Google Scholar
2
2.Mayer, SA, Brun, NC, Begtrup, K, Broderick, J, Davis, S, Diringer, MN, et al.Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med.2008 May 15; 358(20):2127–37.Google Scholar
3
3.Kim, CH, Kim, JS.Development of cerebral infarction shortly after Intracerebral haemorrhage. Eur Neurol. 2007;57:145–9.Google Scholar
4
4.Sinar, EJ, Mendelow, AD, Graham, DI, Teasdale, GM.Experimental Intracerebral haemorrhage: effects of a temporary mass lesion. J Neurosurg. 1987;66:568–76.Google Scholar
6.Zazulia, AR, Diringer, MN, Derdeyn, CP, Powers, WJ.Progression of mass effect after intracerebral hemorrhage. Stroke.1999;Jun;30(6):1167–73.Google Scholar
7
7.Inaji, M, Tomita, H, Tone, O, Tamaki, M, Suzuki, R, Ohno, K.Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl. 2003;86:445–8.Google Scholar